Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

Clever, Personable, and Unconventional

NEWTOWN, Pa., Oct. 02, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that Jeff Mathiesen, Chief Financial Officer, will participate at two upcoming conferences as follows: JonesTrading 2023 Healthcare Summit (1-on-1s Only) […] The post Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences.

Helius Medical Technologies, Inc. is making waves in the medical field with their unique approach to treating balance and gait deficits. The company’s focus on neurotech sets them apart from traditional treatment methods, offering a fresh perspective on therapeutic neuromodulation.

Impact on Individuals

For individuals who suffer from balance and gait deficits, Helius Medical Technologies’ innovative approach could offer new hope for improved mobility and quality of life. By participating in healthcare conferences, the company is taking steps to spread awareness and potentially reach more patients in need of their services.

Global Implications

On a global scale, Helius Medical Technologies’ participation in healthcare conferences could lead to increased collaboration with healthcare professionals and researchers around the world. This could result in advancements in neurotech treatment methods that have the potential to benefit individuals worldwide.

Conclusion

Helius Medical Technologies’ involvement in upcoming healthcare conferences signifies a commitment to advancing the field of neurotech and improving the lives of individuals with balance and gait deficits. With a focus on clever, personable, and unconventional approaches, the company is poised to make a significant impact on the medical industry and individuals around the world.